Clincosm LogoSign in Get a demo

Metastatic Cancer

Showing NaN - NaN of 70
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain Cancer, Glioblastoma, Metastatic Cancer Trial in New York (Trastuzumab deruxtecan)

Recruiting
  • Brain Cancer
  • +4 more
  • Trastuzumab deruxtecan
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Sep 22, 2023

Cutaneous Squamous Cell Carcinoma, SCC - Squamous Cell Carcinoma, Basal Cell Carcinoma Trial in United States (MQ719,

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +18 more
  • Basking Ridge, New Jersey
  • +6 more
May 18, 2023

Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

Recruiting
  • Tumor
  • +20 more
  • Mobile, Alabama
  • +81 more
Jan 24, 2023

Metastatic Castration Resistant Prostate Cancer, Metastatic Cancer, Solid Tumor Trial in United States (Nivolumab, Ipilimumab)

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • +2 more
  • San Diego, California
  • +7 more
Jan 23, 2023

Solid Tumor, Metastatic Solid Tumor, Solid Carcinoma Trial in New York, Seattle (AZD1390, Stereotactic Body Radiotherapy)

Not yet recruiting
  • Solid Tumor
  • +5 more
  • AZD1390
  • Stereotactic Body Radiotherapy
  • New York, New York
  • +1 more
Jan 12, 2023

Advanced Cancer, Metastatic Cancer, Malignant Neoplastic Disease Trial in Puerto Rico, United States (MRTX849, Pembrolizumab,

Recruiting
  • Advanced Cancer
  • +2 more
  • Birmingham, Alabama
  • +97 more
Jan 6, 2023

Metastatic Cancer, Solid Tumors, Advanced Cancer Trial in United States (ASP9801, Pembrolizumab)

Recruiting
  • Metastatic Cancer
  • +2 more
  • ASP9801
  • Pembrolizumab
  • Birmingham, Alabama
  • +26 more
Jan 6, 2023

Advanced Malignancies, Metastatic Cancer Trial in Worldwide (INCAGN01876, Nivolumab, Ipilimumab)

Completed
Has Results
  • Advanced Malignancies
  • Metastatic Cancer
  • Los Angeles, California
  • +37 more
Dec 6, 2022

Non Small Cell Lung Cancer, KRAS Activating Mutation, Advanced Cancer Trial in United States (VS-6766 and adagrasib)

Recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • avutometinib (VS-6766) and adagrasib
  • San Francisco, California
  • +4 more
Dec 21, 2022

Recurrent Cancer, Metastatic Cancer, Advanced Malignancies Trial (INCAGN01876, retifanlimab)

Recruiting
  • Recurrent Cancer
  • +3 more
  • INCAGN01876
  • retifanlimab
  • Birmingham, Alabama
  • +17 more
Dec 13, 2022

Solid Tumor, Metastatic Cancer Trial in United States (RP-3500, External Beam Radiotherapy (EBRT))

Recruiting
  • Solid Tumor
  • Metastatic Cancer
  • RP-3500
  • External Beam Radiotherapy (EBRT)
  • Basking Ridge, New Jersey
  • +6 more
Dec 8, 2022

Metastatic Cancer, Melanoma Cancer, Lung Cancer Trial in United States (Stereotactic Body Radiotherapy, Ipilimumab, Nivolumab,

Recruiting
  • Metastatic Cancer
  • +5 more
  • Stereotactic Body Radiotherapy
  • Ipilimumab, Nivolumab, Pembrolizumab or Atezolizumab
  • Hartford, Connecticut
  • +9 more
Nov 17, 2022

Metastatic Cancer, Solid Tumor Trial in Worldwide (Sym021, Sym022, Sym023)

Active, not recruiting
  • Metastatic Cancer
  • Solid Tumor
  • Aurora, Colorado
  • +17 more
Sep 8, 2022

Metastatic Cancer, Locally Advanced Cancer, Thoracic Cancer Trial in New York (Weekly 45 minute Sessions)

Active, not recruiting
  • Metastatic Cancer
  • +5 more
  • Weekly 45 minute Sessions
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 19, 2022

Advanced Cancer, Metastatic Cancer, Breast Cancer Trial in United Kingdom, United States (ART4215, Talazoparib, Niraparib)

Recruiting
  • Advanced Cancer
  • +2 more
  • Orlando, Florida
  • +6 more
Aug 16, 2022

Advanced Solid Tumor, Advanced Malignant Tumor, Metastatic Cancer Trial in United States (PC14586)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Los Angeles, California
  • +10 more
Aug 12, 2022

Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in China, United States (TJ033721)

Recruiting
  • Solid Tumor
  • +6 more
  • Orange, California
  • +17 more
Aug 9, 2022

Colorectal Cancer, Metastatic Cancer Trial in New Brunswick, New York (FOLFOX regimen, dexamethasone, floxuridine)

Active, not recruiting
  • Colorectal Cancer
  • Metastatic Cancer
  • FOLFOX regimen
  • +7 more
  • New Brunswick, New Jersey
  • +1 more
Jul 1, 2022

Metastatic Cancer, Solid Tumor, Cholangiocarcinoma Trial in United States (LYT-200, Anti-PD-1, Gemcitabine/nab-paclitaxel)

Recruiting
  • Metastatic Cancer
  • +4 more
  • Phoenix, Arizona
  • +15 more
Mar 9, 2022

Colorectal Cancer, Metastatic Cancer Trial in United States (dexamethasone, floxuridine, fluorouracil)

Active, not recruiting
  • Colorectal Cancer
  • Metastatic Cancer
  • Basking Ridge, New Jersey
  • +4 more
Feb 4, 2022

Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)

Recruiting
  • Urothelial Carcinoma
  • +20 more
  • Gilbert, Arizona
  • +9 more
Feb 3, 2022

Metastatic Cancer Trial in United States (Oxycodone/acetaminophen 5/325 mg, Proteus digital medicine program)

Terminated
Has Results
  • Metastatic Cancer
  • Oxycodone/acetaminophen 5/325 mg
  • Proteus digital medicine program
  • Decatur, Illinois
  • +4 more
Dec 9, 2021

Advanced Cancer, Metastatic Cancer, Malignant Neoplastic Disease Trial in United States (MRTX849, TNO155)

Active, not recruiting
  • Advanced Cancer
  • +2 more
  • Los Angeles, California
  • +11 more
Nov 12, 2021

Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)

Active, not recruiting
  • Brain and Central Nervous System Tumors
  • +9 more
  • DNA analysis
  • +4 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 28, 2021

Metastatic Cancer, Prostate Cancer Trial in United States (atrasentan HCl, docetaxel, prednisone)

Completed
Has Results
  • Metastatic Cancer
  • Prostate Cancer
  • atrasentan hydrochloride
  • +3 more
  • Mobile, Alabama
  • +553 more
Oct 8, 2021